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ABSTRACT The mycobacterial cell wall is crucial to the host-pathogen interface, because it provides a barrier against antibiotics and the host immune response. In
addition, cell wall lipids are mycobacterial virulence factors. The mycobacterial
membrane protein large (MmpL) proteins are cell wall lipid transporters that are
important for basic mycobacterial physiology and Mycobacterium tuberculosis pathogenesis. MmpL3 and MmpL11 are conserved across pathogenic and nonpathogenic
mycobacteria, a feature consistent with an important role in the basic physiology of
the bacterium. MmpL3 is essential and transports trehalose monomycolate to the
mycobacterial surface. In this report, we characterize the role of MmpL11 in M. tuberculosis. M. tuberculosis mmpL11 mutants have altered bioﬁlms associated with
lower levels of mycolic acid wax ester and long-chain triacylglycerols than those for
wild-type bacteria. While the growth rate of the mmpL11 mutant is similar to that of
wild-type M. tuberculosis in macrophages, the mutant exhibits impaired survival in
an in vitro granuloma model. Finally, we show that the survival or recovery of the
mmpL11 mutant is impaired when it is incubated under conditions of nutrient and
oxygen starvation. Our results suggest that MmpL11 and its cell wall lipid substrates
are important for survival in the context of adaptive immune pressure and for nonreplicating persistence, both of which are critically important aspects of M. tuberculosis pathogenicity.
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T

uberculosis (TB) is one of the leading causes of death due to infectious disease
despite the availability of antitubercular drugs. The mycobacterial cell wall is
associated with Mycobacterium tuberculosis pathogenesis and provides a barrier against
environmental stresses, antibiotics, and the host immune response. The mycobacterial
cell wall is unique in architecture and composition. The outer membrane contains an
inner leaﬂet of very-long-chain mycolic acids covalently bound to the arabinogalactanpeptidoglycan layer and an outer leaﬂet composed of noncovalently associated lipids,
such as phthiocerol dimycocerosate (PDIM), sulfolipids, and trehalose 6,6=-dimycolate
(TDM) (1, 2). These surface-exposed lipids are immunomodulatory and play a role in
host-pathogen interactions (3–9).
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The mycobacterial membrane protein large (MmpL) proteins are cell wall lipid
transporters that are crucial contributors to mycobacterial physiology and pathogenesis (10–18). MmpL3 is essential and transports trehalose monomycolate (TMM), the
TDM precursor, to the mycobacterial surface (19). TDM biosynthesis and incorporation
into the mycobacterial cell wall are required for mycobacterial replication and viability
(20, 21). MmpL4, MmpL5, MmpL7, MmpL8, MmpL10, and MmpL11 are required for full
M. tuberculosis virulence (22, 23). MmpL4 and MmpL5, along with their accessory MmpS
proteins, are involved in M. tuberculosis siderophore export (24). MmpL7 and MmpL8
transport PDIM and sulfolipid-1, respectively, to the outer leaﬂet of the M. tuberculosis
cell wall, where these surface-exposed lipids function as virulence determinants (3, 9).
MmpL10 is required for transport of diacyltrehalose to the M. tuberculosis periplasm,
where it is converted to penta-acyltrehalose (18). The substrates of MmpL11 in M.
tuberculosis have not yet been identiﬁed.
While all mycobacteria possess genes encoding MmpL proteins, the number in each
species can differ. For instance, Mycobacterium leprae possesses 5 intact mmpL genes,
whereas there are 31 mmpL genes in M. abscessus. In addition, differences exist in
MmpL substrates among species. While MmpL4 is required for siderophore export in M.
tuberculosis, it is involved in glycopeptidolipid transport in M. smegmatis and M. bolletii
(15, 24–26). Furthermore, the M. smegmatis homologue of MmpL10 transports trehalose polyphleates instead of diacyltrehalose (16). We demonstrated previously that in
M. smegmatis, MmpL11 is important for bioﬁlm formation and transports monomeromycolyl diacylglycerol (MMDAG), a specialized triacylglycerol (TAG) molecule, and
mycolate wax ester (MWE) (10). Heterologous expression of M. tuberculosis mmpL11 in
an M. smegmatis mmpL11 mutant complemented the bioﬁlm phenotype, suggesting
that MmpL11 transports similar substrates in the two species.
Two studies independently showed that an M. tuberculosis mmpL11 mutant is
attenuated in a mouse model of infection (22, 23). While M. tuberculosis mmpL11
mutants infected mice like wild-type M. tuberculosis, MmpL11 was required for bacterial
survival during later stages of chronic infection (22). Neither study identiﬁed the
mechanism by which the mutant was attenuated or determined the substrate of
MmpL11. To further characterize the role of MmpL11 in M. tuberculosis, we constructed
and characterized an M. tuberculosis mmpL11 mutant. In agreement with a conserved
role in mycobacterial physiology, we show that M. tuberculosis mmpL11 mutants have
altered bioﬁlm formation. When grown under bioﬁlm-inducing conditions, surface
lipids, including an MWE and long-chain TAGs, are altered in the mmpL11 mutant
relative to the wild type, suggesting that these apolar lipids are the MmpL11 substrates
in M. tuberculosis. We found that the mmpL11 mutant was able to replicate like the wild
type in cultured macrophages, but by capitalizing on an in vitro granuloma model
generated from individuals with latent TB infection (LTBI), we show that the mmpL11
mutant is less ﬁt than wild-type M. tuberculosis in the face of adaptive immune pressure.
Finally, we show that the mmpL11 mutant is impaired for survival and/or resuscitation
relative to wild-type M. tuberculosis when incubated under conditions of nutrient and
oxygen starvation. Combined, these data suggest that MmpL11 and its substrates are
important for intracellular growth, nonreplicating persistence, and latency.
RESULTS
Mmpl11 plays a conserved role in mycobacterial bioﬁlm formation. To experimentally determine whether MmpL11 function is conserved, we constructed an allelic
exchange mutant in H37Rv to characterize the role and function of MmpL11 in M.
tuberculosis. There were no differences in the growth rate between wild-type M.
tuberculosis and the mmpL11 mutant when they were grown planktonically in 7H9
medium containing Tween 80 (Fig. 1A). When the mycobacteria were grown in Sauton’s
medium lacking Tween 80 to induce bioﬁlm formation, we observed that the absence
of MmpL11 resulted in a weaker bioﬁlm that was slower to form than that for wild-type
bacteria (Fig. 1B). To quantify bioﬁlm formation, we stained the bioﬁlm material that
adhered to the wells of a 96-well plate with crystal violet. The level of crystal violet
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FIG 1 The M. tuberculosis mmpL11 mutant exhibits impaired bioﬁlm formation that does not result from
reduced replication in Sauton’s medium. (A) Growth of M. tuberculosis wild-type and mmpL11 mutant
strains in 7H9 medium. Average values and standard deviations for four biological replicates are shown.
(B) Bioﬁlm formation by M. tuberculosis wild-type, mmpL11 mutant, and complemented strains. Bioﬁlms
were cultured in 6-well plates for a total of 4 weeks. (C) Quantiﬁcation of crystal violet staining of M.
tuberculosis bioﬁlms. Average values and standard deviations for three independent assays are shown.
The difference between the wild type and the mutant was signiﬁcant (P, ⬍0.005 by Student’s t test). (D)
The numbers of wild-type, mutant, and complemented M. tuberculosis bacteria present when strains
were grown as bioﬁlms were determined by mechanically disrupting 3-week bioﬁlms. Bacteria representing both bioﬁlm and planktonic bacteria were serially diluted and were plated onto 7H11 agar
containing ADS and 0.5% glycerol for the determination of the CFU count per milliliter. (E) The growth
of wild-type, mutant, and complemented M. tuberculosis strains in Sauton’s medium containing Tween
80 was followed by measuring the OD600. An asterisk indicates that the difference between wild-type and
mmpL11 mutant bacteria at that time point was signiﬁcant (P ⫽ 0.029). (F) The bacterial CFU counts per
milliliter at the indicated time points were determined by plating serial dilutions. The difference between
the wild type and the mmpL11 mutant was not signiﬁcant when they were quantiﬁed by this methodology. (G) The mmpL11 mutant forms small colonies on 7H11 agar containing ADS and 0.5% glycerol.

staining for the mutant wells was signiﬁcantly lower than that for the wild-type wells
(Fig. 1C). The impaired bioﬁlm phenotype was complemented via expression of M.
tuberculosis MmpL11 (MmpL11Mt). Two complementation strategies were used for the
M. tuberculosis mmpL11 mutant. The pVV16mmpL11 plasmid constitutively expressed
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mmpL11 from an hsp60 promoter. The mmpL11/pVV16mmpL11 strain developed a
reticulated bioﬁlm faster than wild-type M. tuberculosis (Fig. 1B, top). We speculate that
this occurs because of constitutive overexpression of MmpL11. Our second complementation approach used an integrative pMV306mmpL11 construct where mmpL11
was cloned with the 1,000-bp region upstream such that mmpL11 expression would be
under the control of its native promoter. While we anticipated that the levels of
mmpL11 would be equivalent to those in wild-type bacteria, expression of the mmpL11
gene in the mmpL11::pMV306mmpL11 strain was 5-fold higher than that of the wild
type (5.54-fold ⫾ 0.483-fold over three biological replicates).
Reduced bioﬁlm formation may result if the mmpL11 mutant grows more slowly
than the wild type under bioﬁlm-inducing conditions. To determine if this was the case,
bioﬁlms grown in 24-well plates were mechanically disrupted, and serial dilutions of the
well contents were plated on 7H11 medium such that both the bacteria in the bioﬁlm
and those growing planktonically were represented. There was no difference between
the CFU counts of the wild type and the mmpL11 mutant present in the wells (Fig. 1D).
This result suggests that the mmpL11 mutant is able to replicate like the wild type
under bioﬁlm-inducing conditions but does so planktonically instead of developing a
robust bioﬁlm. To formally assess the growth of the M. tuberculosis mmpL11 mutant in
Sauton’s medium, growth curves were performed and bacterial numbers determined
by measuring the optical density at 600 nm (OD600) and by plating serial dilutions on
agar plates over a time course. Mycobacterial strains were cultured in Sauton’s medium
containing Tween 80 to avoid the variability associated with mechanical disruption
of bioﬁlm-associated bacteria. Growth curves performed using optical density
consistently showed differences between the M. tuberculosis mmpL11 mutant at the
late-exponential-growth phase and wild-type M. tuberculosis (Fig. 1E). However,
when the CFU per milliliter were enumerated, there was not a signiﬁcant difference
(Fig. 1F). In addition, it is noteworthy that the M. tuberculosis mmpL11 mutant formed
smaller colonies than the wild type on 7H11 agar (Fig. 1G). This particular phenotype
may be species speciﬁc, since the M. smegmatis mmpL11 mutant did not exhibit a
growth defect in liquid media or on agar plates (10).
The lipid proﬁles of the mmpL11 mutant are distinct from those of wild-type M.
tuberculosis. To identify the substrates of the MmpL11 transporter, we examined the
lipid proﬁles of the M. tuberculosis mmpL11 mutant grown under both planktonic and
bioﬁlm conditions using thin-layer chromatography (TLC). There were no differences
between the lipids isolated from the mmpL11 mutant and those from wild-type M.
tuberculosis when the strains were grown planktonically, in agreement with our observation that there were no defects in planktonic growth (data not shown). However, we
noted several differences between lipids isolated from wild-type M. tuberculosis and the
mmpL11 mutant grown as bioﬁlms. When surface and total lipids were resolved by TLC
in the chloroform-methanol-distilled water (dH2O) (90:10:1) solvent system, we saw that
the surface levels of TDM in the mmpL11 mutant were lower than those in the wild
type, while the levels of free mycolic acids (FM) were increased (Fig. 2A). Previous
studies have shown that free mycolic acids are hydrolyzed from TDM and contribute to
mycobacterial bioﬁlm formation (27, 28). Therefore, it is possible that the mmpL11
mutant compensates in part for the absence of other bioﬁlm-associated lipids by
producing greater amounts of free mycolic acids.
When M. tuberculosis lipids were resolved by TLC in the toluene-acetone (99:1)
solvent system, we saw the loss of two surface-extractable lipids in the mmpL11 mutant
(Fig. 2B). One was slightly more apolar than the commercial wax ester standard
(annotated as “a” in Fig. 2B), and the other migrated alongside the commercial TAG
standard (annotated as “b” in Fig. 2B). Complementation with either the integrative or
the episomal mmpL11 vector restored all lipids to wild-type levels (Fig. 2 and data not
shown). Lipid species “a” was identiﬁed by mass spectrometry (MS) as mycolic acid wax
ester, which consisted of a tritriacontadienol (33:2) linked to the mycolic acid via an
ester bond to form a tritriacontadienyl mycolate ester (see Fig. S1A and B in the
supplemental material). This result is consistent with the M. smegmatis MWE reported
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FIG 2 The M. tuberculosis mmpL11 mutant possesses altered cell wall lipids when cultured under
bioﬁlm-inducing conditions. (A) Hexane-extractable surface lipids (left) and total apolar lipids (right) were
extracted from M. tuberculosis bioﬁlms and were resolved by TLC in chloroform-methanol-dH2O (90:10:1,
vol/vol/vol). Free mycolic acids (FM) and the trehalose dimycolate (TDM) standard (Sigma) are indicated.
(B) Hexane-extractable surface lipids (left) and total apolar lipids (right) were resolved by TLC in
toluene-acetone (99:1, vol/vol). The triacylglycerol (TAG) and wax ester (WE) standards (Sigma) are
indicated. Unknown lipids “a” and “b” are noted. In the experiments for both panels, TLC plates were
sprayed with MPA and were charred to visualize lipids. Lipids that are absent in the mmpL11 mutant are
outlined, and a lipid that appears to accumulate is indicated by an asterisk.

previously (10). The mycolic acid constituents of the MWE from wild-type M. tuberculosis
comprised predominantly methoxy-mycolic acids (marked with an asterisk in Fig. S1A
and B), the proﬁle of which resembled that of the methoxy-mycolic acids found in
wild-type M. tuberculosis (marked with an asterisk in Fig. S1C). We were unable to detect
the corresponding ␣-mycolic acid- and keto-mycolic acid-containing MWEs, suggesting
that the abundances of these species are too low for them to be detected using the
present approach. When we examined the mycolic acids present in total lipids, we
found that the ␣-mycolic acid and keto-mycolic acid are also minor species (marked
with a number sign and a dagger in Fig. S1C), so the mycolic acid representation of the
MWE is consistent with the overall mycolic acid composition of the bacterium. The
mycolic acid composition of our bioﬁlm-grown bacteria is consistent with what others
have reported recently for H37Rv cultured on Ogawa agar, although we acknowledge
that different growth conditions can change the mycolic acid proﬁles of mycobacteria
(29).
Mass spectrometry analysis of spot “b” revealed that it comprised TAGs with
very-long-chain (C20 to C38, with 0-1 unsaturation) fatty acid constituents (see Fig. S2 in
the supplemental material). The electrospray ionization (ESI) mass spectra of TAGs from
the wild type (Fig. S2A) and the mmpL11 mutant (Fig. S2B) appeared similar, although
long-chain TAGs with full saturation appeared to be less abundant in the mutant.
Combined, these ﬁndings suggest that MWE and very-long-chain fatty acid-containing
August 2017 Volume 85 Issue 8 e00131-17
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FIG 3 M. tuberculosis mmpL11 mutant bacteria are shorter than the wild type in bioﬁlms. Shown are
representative images (left) and quantiﬁcation of the lengths (right) of M. tuberculosis strains grown in
either Sauton’s medium lacking Tween 80, to promote bioﬁlm formation (A), Sauton’s medium containing Tween 80 (B), or 7H9 medium containing Tween 80 (C). The differences between the wild type and
the mutant were signiﬁcant by Student’s t test (***, P ⬍ 0.005; *, P ⬍ 0.05).

TAGs are substrates of the MmpL11 transporter. The lack of surface-exposed lipids
associated with bioﬁlms likely contributes to the reduced bioﬁlm phenotype.
mmpL11 mutant cells are shorter than wild-type M. tuberculosis cells. Since the
M. tuberculosis mmpL11 mutant had altered cell wall-associated lipids when grown as
bioﬁlms, we wondered if there were changes to acid fastness or bacterial morphology.
Bioﬁlms were mechanically disrupted and bacteria ﬁxed for microscopy. We did not see
a difference in acid-fast staining between wild-type and mmpL11 mutant bacteria (data not
shown). However, there was a striking difference in cell length between mmpL11 mutant
bacteria and wild-type M. tuberculosis (Fig. 3A). Quantiﬁcation indicated an average cell
length of 3.706 ⫾ 0.1119 m for wild-type bacteria versus 2.287 ⫾ 0.05797 m for the
mmpL11 mutant. Bacterial size was restored upon complementation. Because mmpL11
mutant bacteria grown as bioﬁlms had a reduced cell length, we investigated whether
these bacteria were also shorter when grown planktonically in Sauton’s medium or 7H9
medium containing Tween 80. The short bacterium phenotype was less pronounced in
the planktonically grown mutant, but cell lengths still differed signiﬁcantly between
mutant and wild-type bacteria (Fig. 3B and C), which could explain why the mmpL11
August 2017 Volume 85 Issue 8 e00131-17
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FIG 4 Transmission electron microscopy reveals differences in ultrastructure between the wild-type and
mmpL11 mutant M. tuberculosis strains grown in 7H9 medium containing Tween 80 (left) (planktonic) or
Sauton’s medium without Tween 80 (right) (bioﬁlm). Arrows indicate crystal inclusions in mmpL11
mutants grown planktonically. Asterisks highlight the extracellular material that is enriched in the
mmpL11 mutant relative to wild-type M. tuberculosis.

mutant bacteria appeared to have a growth defect when growth curves were acquired
using the OD600.
Finally, we performed transmission electron microscopy (TEM) to determine whether
there were ultrastructural differences between wild-type and mmpL11 mutant M.
tuberculosis bacteria. Intriguingly, planktonic mmpL11 mutant bacteria were distinct
from the wild type in that they accumulated electron-light inclusions (Fig. 4, left). While
some inclusions were consistent with lipid droplets or vesicles, others had a crystalline
appearance (indicated by arrows). Our data indicate that even during planktonic
growth, when the mmpL11 mutant lacks an apparent phenotype, loss of the MmpL11
transporter still impacts bacterial physiology. The mmpL11 mutant was also distinct
from the wild type when grown as a bioﬁlm: there appeared to be more extracellular
material surrounding mmpL11 mutant bacteria than around wild-type bacteria (Fig. 4,
right).
The M. tuberculosis mmpL11 mutant is impaired for survival in an in vitro
human granuloma model. Mice infected with the mmpL11 mutant survive longer than
those infected with wild-type M. tuberculosis (22). The M. tuberculosis mmpL11 mutant
did not have a defect in the acute stages of mouse infection; however, fewer mmpL11
mutant bacteria than wild-type bacteria were recovered during the chronic stage of
infection. In agreement with this observation, the mmpL11 mutant did not have a
replication defect in the human THP-1 monocyte-derived macrophage line (Fig. 5A).
Although the macrophage is the host niche most studied using in vitro models of
infection, natural tuberculosis infections and control of the bacterium involve multiple
cell types. To assess the phenotype of the mmpL11 mutant in a more complex system
that includes cells involved in the innate and adaptive immune responses, we used an
in vitro granuloma model generated from peripheral blood mononuclear cells (PBMCs)
from individuals with latent TB infection (LTBI) who had a positive result with the
Mantoux tuberculin skin test (TST) and/or gamma interferon (IFN-␥) release assay (IGRA)
(TST⫹ or IGRA⫹, respectively) (30). Previous characterization of the granulomas showed
that these structures include macrophages and multinucleated giant cells (CD11b⫹), T
cells (CD3⫹, CD4⫹, CD8⫹), and B cells (CD19⫹ cells) and that M. tuberculosis resides
within the dense cellular aggregates of the granuloma. These cells are viable, and the
T cells are able to proliferate over the time course of infection, as indicated by
5-ethynyl-2=-deoxyuridine (EdU) labeling (30). Granuloma structures generated from
PBMCs from individuals with LTBI control M. tuberculosis growth more efﬁciently than
granulomas generated from naïve individuals, a phenomenon related to stronger
immune pressure against the bacteria. We observed signiﬁcantly fewer viable bacteria
of the mmpL11 mutant strain than of the complemented strain 7 days following
infection (Fig. 5B). The growth of the mmpL11 mutant was also reduced from that of
wild-type bacteria, but this difference did not reach signiﬁcance. In addition, granuloma
formation was signiﬁcantly delayed for the mmpL11 mutant relative to the wild type,
August 2017 Volume 85 Issue 8 e00131-17
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FIG 5 The M. tuberculosis mmpL11 mutant has a survival defect in an in vitro granuloma model
containing human innate and adaptive immune cells. (A) Survival of wild-type, mutant, and complemented M. tuberculosis strains in differentiated THP-1 cells. Average values and standard deviations for
a representative experiment performed in triplicate are shown. (B) Survival of wild-type, mutant, and
complemented M. tuberculosis strains in an in vitro granuloma model. The relative survival of strains at
7 days (average values ⫾ standard errors of the means for two experiments, performed in triplicate) is
shown. The difference between the mutant and the complemented strain was signiﬁcant by Student’s
t test (*, P ⬍ 0.05). (C) Representative images of granulomas formed in vitro 5 and 7 days after infection
with M. tuberculosis. Magniﬁcation, ⫻40. Granuloma formation was scored for each condition; the means ⫾
standard deviations of scores representative of two experiments each are given below the images.

and this was partially restored with the complemented strain (Fig. 5C). This was
noticeable within just 4 or 5 days of infection, as shown by the representative images
and the scoring index, which ranks the granuloma structure on a scale from 1 to 5, with
progressive increases in the size and speciﬁc cell distribution of granulomas (30). We
conﬁrmed that the granuloma structures formed following infection with wild-type,
mmpL11 mutant, or complemented M. tuberculosis strains contain CD3⫹ T cells and
CD68⫹ macrophages (Fig. 6A and B) and that the bacteria are located within the
granuloma structures (Fig. 6C). These granuloma structures have lower expression of
CD163⫹ and CD206⫹ cells than uninfected macrophages (see Fig. S3 in the supplemental material), potentially representing an early granulomatous response (31, 32).
To better understand the mechanism underlying delayed granuloma formation, we
evaluated the ability of M. tuberculosis-speciﬁc CD8⫹ T cell clones to recognize and
respond to autologous dendritic cells (DCs) infected with wild-type or mmpL11 mutant
bacteria. We plated CFU of the wild-type and mutant strains at 0 and 18 h and found
no signiﬁcant differences in either the infection rate or the survival of the mutant over
this period, in agreement with the phenotype of the mutant in THP-1 monocytederived macrophages (data not shown). Despite being infected with equivalent numAugust 2017 Volume 85 Issue 8 e00131-17
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FIG 6 In vitro granuloma structures contain CD3⫹ and CD68⫹ cells and M. tuberculosis. In vitro granuloma
structures were ﬁxed at 7 days and were labeled for CD3 (A), CD68 (B), and M. tuberculosis (C) to conﬁrm
that granuloma composition was consistent with that found in our previous work (30). Images are
representative of two experiments.

bers of bacteria, DCs infected with the mmpL11 mutant were less able than those
infected with the wild type to stimulate IFN-␥ production by four T cell clones that
recognize distinct M. tuberculosis antigens (see Fig. S4A in the supplemental material).
CD8⫹ T cell responses to M. tuberculosis-infected cells require that antigens be
secreted from the bacterium and delivered to the major histocompatibility complex
type I (MHC-I) processing and presentation pathway. Based on these data, we considered the possibility that lower CD8⫹ T cell responses to the mutant than to the wild
type corresponded to reduced antigen secretion across the mmpL11 bacterial membrane into the host environment because of altered cell wall composition. Western blot
analysis of total lysates and culture ﬁltrate proteins (CFP) using antibodies against
Antigen 85 and ESAT-6 showed that there are lower levels of these proteins in the liquid
growth medium of the mmpL11 mutant than in that of wild-type M. tuberculosis (Fig.
S4B). Therefore, we speculate that in the host cell, the mmpL11 mutant is less immunogenic than wild-type M. tuberculosis, resulting in slower T cell activation and delayed
granuloma formation.
The differences observed in the secreted protein levels in the mmpL11 mutant may
be results of general differences in the cell wall rather than impacts on speciﬁc
secretion systems. In support of this possibility, we see reduced IFN-␥ levels induced by
T cell clones that recognize substrates of the ESX (type VII) secretion system, as well as
T cell clone 454H1-2, which recognizes Rv1174c (also known as Mtb8.4). Rv1174c has a
predicted N-terminal signal sequence suggesting secretion by the Sec system, and
proteomic studies have identiﬁed both the cleaved signal peptide and mature Rv1174c
in the CFP (33). To determine if there were differences in cell wall permeability that may
impact protein release, we performed an ethidium bromide uptake assay. The mmpL11
mutant had lower membrane permeability than wild-type M. tuberculosis (Fig. S4C). This
result is consistent with the reduced membrane permeability we observed for the M.
smegmatis mmpL11 mutant (34). It is reasonable that if small molecules take longer to
diffuse into the bacterium, molecules and proteins will take longer to diffuse out of the
bacterium into the growth medium and, by extension, into the host cell.
The M. tuberculosis mmpL11 mutant is impaired for survival and resuscitation
from nonreplicating persistence. M. tuberculosis is also subject to nutritional stress
during infection and has adapted to utilize multiple host-derived carbon sources. It is
thought that M. tuberculosis utilizes host cholesterol during infection, and a genetic
screen has indicated that MmpL11 is required for growth on cholesterol (35). To
determine if this underlies the attenuation of the M. tuberculosis mmpL11 mutant
August 2017 Volume 85 Issue 8 e00131-17
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FIG 7 (A) Growth of wild-type, mutant, and complemented M. tuberculosis strains in Sauton’s medium
containing cholesterol as the sole carbon source. Average values and standard deviations for three
biological replicates are shown. (B) Survival of wild-type, mutant, and complemented M. tuberculosis
strains in an in vitro model of dormancy. Average values and standard deviations for a representative
experiment performed in triplicate are shown. The difference between the wild type and the mutant was
signiﬁcant by Student’s t test (*, P ⬍ 0.05; **, P ⬍ 0.01).

during persistent infections, we followed bacterial growth in Sauton’s medium containing cholesterol as the sole carbon source. For this set of experiments, we utilized
the surfactant tyloxapol to avoid the possibility of Tween 80-derived oleic acid complicating the interpretation of cholesterol utility. There was no signiﬁcant difference
between the growth of the mmpL11 mutant and wild-type M. tuberculosis when growth
was measured using the OD600 (Fig. 7A) or when CFU per milliliter were enumerated by
plating serial dilutions (data not shown).
Since TAGs and wax esters are implicated in M. tuberculosis dormancy (36–39), we
investigated whether the M. tuberculosis mmpL11 mutant was able to survive or recover
from in vitro dormancy conditions. We washed and resuspended M. tuberculosis bacteria in phosphate-buffered saline (PBS) for 2 and 6 weeks, and then we plated serial
dilutions to quantify the surviving bacteria. The mmpL11 mutants recovered very slowly
from these conditions, and there was an 85% reduction in countable colonies from the
6-week cultures (Fig. 7B). Taken together, these results indicate that MmpL11 and the
MmpL11 substrates are important for survival or resuscitation from a nutrient-starved,
hypoxia-induced dormancy model.
DISCUSSION
In this report, we characterized the role of MmpL11 in M. tuberculosis. Our analysis
of the M. tuberculosis mmpL11 mutant lipids indicated that the transport of MWE and
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long-chain TAGs to the bacterial surface is disrupted. The absence of MmpL11 has
impacts on bacterial physiology that range from reduced bioﬁlm formation to changes
in cell size and attributes, including reduced membrane permeability, which may
inﬂuence the release of secreted proteins from the bacterium into the environment. We
observed that the M. tuberculosis mmpL11 mutants have a morphology and ultrastructural appearance distinct from those of the wild type when grown in broth culture and
bioﬁlms, which may result from the inability of the mutant to transport its lipid
substrates. Transmission electron microscopy showed that planktonic mmpL11 mutant
bacteria accumulated electron-light crystalline inclusions. We were unable to identify
these inclusions, but they are reminiscent of the inclusions observed upon tetrahydrolipstatin (THL) treatment of M. kansasii (40). THL inhibits the synthesis of mycolic acids,
and the authors of the previous study (40) speculated that these inclusions represented
mycolic acid precursors or FAS-1 products esteriﬁed to storage molecules. Therefore,
we suspect that these inclusions result from the accumulation of MWE or an MWE
intermediate in the bacterial cytoplasm.
MmpL11 is required for full virulence of M. tuberculosis in mice (22, 23). While the
mutant infected and replicated like the wild type during the acute phase of infection,
fewer bacteria were present during the chronic, persistent phase of infection. There was
a signiﬁcant increase in the time to death of mice infected with the mmpL11 mutant
(333 days) over that for mice infected with wild-type M. tuberculosis (173 days) (22). The
mmpL11 mutant can therefore be classiﬁed as an M. tuberculosis “persistence mutant.”
Mutants that share this phenotype include those that are less ﬁt in the face of adaptive
immune pressure, as well as mutants, such as those lacking Icl and Mce4, that have
impaired metabolism or nutrient uptake (41, 42).
The attenuation of the mmpL11 mutant during the chronic phase of infection is
likely multifactorial. Our results indicate that the mmpL11 mutant is less ﬁt in the
presence of adaptive immune cells than wild-type M. tuberculosis. Granuloma formation
is a hallmark of tuberculosis but has been studied primarily in vivo, since it requires the
coordination of innate and adaptive immune cells. Several approaches to modeling
granuloma formation in vitro using human PBMCs have allowed investigators to gain
insight into this aspect of disease. In the context of mycobacteria or mycobacterial
antigens, the aggregation of cells occurs within days and can recapitulate the generation of multinucleated cells and epithelioid macrophages that associate with surrounding macrophages and lymphocytes (43). We used an in vitro granuloma model
that cultured human PBMCs from individuals with previous exposure to mycobacteria
(LTBI; TST⫹ or IGRA⫹ subjects). We showed previously that granuloma formation is
faster, more robust, and better able to control the microbial burden in TST⫹ or IGRA⫹
donors than in their TST⫺ or IGRA⫺ counterparts (30). The results obtained with this
model demonstrate that granulomas form less efﬁciently in response to the mmpL11
mutant, perhaps due to altered cell wall lipid composition and the reduced release of
bacterial proteins. The mmpL11 mutant was also more susceptible than the wild type
to killing by the cells in the granuloma.
Changes in the lipid composition of the mycobacterial cell wall also likely contribute
to the attenuation of the mmpL11 mutant. Speciﬁcally, when grown under bioﬁlminducing conditions, MWE and long-chain TAGs are absent from the mmpL11 mutant
surface-extractable lipids. TAGs and wax esters are associated with M. tuberculosis
dormancy, and nonreplicating bacteria are found within human granulomas (36–39).
Therefore, we suspected that the ability of the mmpL11 mutant to replicate or recover
from the host might also be impaired. Indeed, the survival or resuscitation of the
mmpL11 mutant was signiﬁcantly reduced compared to that of wild-type M. tuberculosis in an in vitro dormancy model. The role of long-chain TAGs and mycolate wax
esters remains an active area of research in the lab. We are identifying the enzymes
responsible for their biosynthesis with the mindset that the characterization of mutants
lacking these individual lipid constituents will reﬁne our understanding of their functions in M. tuberculosis.
Finally, the mmpL11 mutant may also have a defect in nutrient acquisition in the
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host environment. Both MmpL3 and MmpL11 have been implicated in heme transport
(44). Although import of heme or heme complexes may be one function of these
transporters, our data and those of others suggest that MmpL3 and MmpL11 are lipid
exporters with a primary function in cell wall biosynthesis (10, 19, 45). We do not think
that the mmpL11 mutant bacteria are experiencing iron starvation in our studies. The
7H9, 7H11, and Sauton media used in the experiments presented in this report are
considered iron-replete and possess sufﬁcient iron concentrations for bioﬁlm formation, and our mmpL11 mutant produces siderophores. It is proposed that during
infection, M. tuberculosis utilizes host cholesterol as a carbon source. Mutants lacking
cholesterol transporters or catabolic enzymes showed attenuated virulence (42), and a
genetic screen indicated that MmpL11 was required for growth on cholesterol (35).
Mutants containing transposon insertions in mmpL11 were underrepresented 8-fold
following growth on cholesterol as the sole carbon source. However, this phenotype
was not as extreme as that observed for mutants containing transposon insertions in
genes encoding the Mce4 transporter locus or genes for cholesterol catabolism, which
were underrepresented ⬃20- to 90-fold. Furthermore, we did not observe a dramatic
difference between the mmpL11 mutant and the wild type when grown on cholesterol
as the sole carbon source.
Despite evidence that the mmpL11 mutant can grow on cholesterol, we present
other data that may suggest that the ability of the mmpL11 mutant to acquire nutrients
is impaired. Although 7H11 medium is not considered a nutrient-restricted or minimal
medium, the mmpL11 mutant had a small-colony phenotype on 7H11 agar. Nutrient
restriction may also explain the shorter cell length of the mmpL11 mutant than of wild-type
M. tuberculosis. Previous studies have shown that mycobacterial cell division depends on
time, not cell length (46). The cell length of mycobacteria changes depending on the
growth stage, with longer bacteria present during logarithmic growth and shorter bacteria
present during stationary phase, as nutrients are depleted (47). The mmpL11 mutant may
not acquire nutrients as efﬁciently as the wild type in stationary-phase or bioﬁlm
cultures, and perhaps as a result, the mutant does not reach the length of wild-type
bacteria before division, resulting in shorter bacilli.
MmpL11 is required for efﬁcient bioﬁlm formation in both M. tuberculosis and M.
smegmatis. While this phenotype is similar for the fast-growing nonpathogenic and
slow-growing species, there are notable differences in MmpL11 substrates and in the
impact of the mmpL11 mutation on mycobacterial growth. We identiﬁed MWE and
long-chain TAGs as the substrates of MmpL11Mt, whereas MWE and MMDAG are the
substrates of MmpL11 in M. smegmatis. MMDAG has been observed in M. kansasii and
M. smegmatis; however, we were unable to ﬁnd MMDAG in lipids isolated from the M.
tuberculosis H37Rv or Erdman strain. These results suggest that M. tuberculosis produces
very little or none of this mycolic acid-containing lipid. Another difference we observed
was that M. tuberculosis mmpL11 mutant bacteria formed colonies smaller than those
formed by the wild type on standard 7H11 agar. We did not observe any growth defects
in the M. smegmatis mmpL11 mutant (10). M. tuberculosis mmpL11 mutant bacteria
appear shorter than wild-type bacteria in stationary cultures, a phenotype that we also
have not observed for M. smegmatis. Combined, these results suggest that the loss of
MmpL11 function has a greater impact on the physiology of slow-growing or pathogenic mycobacteria than on the nonpathogenic surrogate species M. smegmatis.
MmpL3 and MmpL11 are encoded at a genomic locus that is conserved across
pathogenic and nonpathogenic mycobacteria, including M. leprae, suggesting that they
are important for the basic biology and physiology of mycobacteria. Our working
model is that MmpL3 and MmpL11 are conserved and part of the “core” mycobacterial
genes, because they are required for the two phases of mycobacterial existence.
MmpL3 is essential for active replication, because exported TMM is required for TDM
biosynthesis and cell wall generation. MmpL11 is important for nonreplicating persistence, because it is required for the transport of mycolic acid-containing “storage
lipids.” Since the majority of M. tuberculosis infections result in latent TB, where bacteria
have altered metabolism and exhibit phenotypic drug tolerance, proteins required for
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dormancy and resuscitation, including MmpL11, are putative therapeutic targets. In
particular, the essential MmpL3 protein represents a target for mycobacterial drug
development. In recent years MmpL3 has been identiﬁed as the target of several
compounds by use of genetic approaches (19, 48–50). Ultimately, these compounds
appear to indirectly inhibit MmpL3 by perturbing the proton motive force (PMF) (51,
52). The point-substituted residues identiﬁed in MmpL3 that confer resistance likely
allow the protein to compensate for a disruption of PMF strength. Further studies on
MmpL3, MmpL11, and other virulence-associated MmpL proteins are warranted to
facilitate the development of compounds that inhibit these critical proteins and to
better characterize the mycobacterial cell wall during various phases of infection.
MATERIALS AND METHODS
Maintenance of bacterial cultures and cells. The M. tuberculosis wild-type strain H37Rv was
obtained from the ATCC. Mycobacterial strains were routinely maintained in Middlebrook 7H9 liquid
medium (Difco) or on Middlebrook 7H11 agar (Difco) plates supplemented with 10% oleic acid-albumindextrose-catalase (OADC; Difco) or albumin dextrose salts (ADS) containing 8.1 mg ml⫺1 NaCl, 50 mg
ml⫺1 bovine serum albumin (BSA), and 20 mg ml⫺1 dextrose. Glycerol was added to 7H9 and 7H11 media
at a ﬁnal concentration of 0.5%. Where indicated, bacteria were cultured in Sauton’s medium containing
0.5 g liter⫺1 K2HPO4, 0.5 g liter⫺1 MgSO4, 4.0 g liter⫺1 L-asparagine, 0.05 g liter⫺1 ferric ammonium citrate,
4.76% glycerol, and 1.0 mg liter⫺1 ZnSO4, with a ﬁnal pH of 7.0. For growth on cholesterol as the sole
carbon source, Sauton’s medium that contained 0.5 mM cholesterol and 0.025% tyloxapol (Ty) was
prepared. When required, cultures were incubated with kanamycin (25 g ml⫺1) or hygromycin (50 g
ml⫺1).
The M. tuberculosis mmpL11 mutant was constructed by allelic exchange as follows. Roughly 500-bp
fragments of the 5= and 3= regions of the M. tuberculosis mmpL11 gene were ampliﬁed by PCR using
primers mmpL11xho (5=-CTCGAGGATCGACCGATAGCACCG-3=) and mmpL11kpn (5=-GGTACCCTGCCGTG
CTAGCAACATT-3=) and primers mmpL11BamHI (5=-GATCCGGACCTCCTCCCACTTTG-3=) and mmpL11H3
(5=-AAGCTTGTGTGGATGTGACGGTAAGG-3=), respectively, and were cloned to ﬂank the hygromycin
resistance gene in pYUB854-rpsL (53). The resulting plasmid was transformed into electrocompetent
M. tuberculosis strain H37Rv. Transformants were selected on 7H11 medium containing OADC supplements and 75 g ml⫺1 hygromycin. Individual colonies were streaked onto complete 7H11 agar
containing 50 g ml⫺1 hygromycin. The mutant was conﬁrmed by PCR. For complementation,
primers mmpL11compXba (5=-TTTCTAGACGGCAAGTACTGGTGGTTG-3=) and mmpL11compH3 (5=-GCAA
GCTTCGAATGGCGACGGTAGG-3=) were used to amplify M. tuberculosis mmpL11 including 1,000 bp of
upstream sequence. This fragment was cloned into the integrative plasmid pMV306Kan (54), which was
then transformed into the mmpL11 mutant. The pVV16mmpL11TB plasmid has been described previously
(10).
Bioﬁlm growth conditions. M. tuberculosis bioﬁlm growth conditions were essentially those described previously (27). Brieﬂy, bacteria were cultured in Sauton’s medium without Tween 80 in
polystyrene bottles (Corning). Flasks were incubated at 37°C under 5.5% CO2 with tightened caps for 2
weeks. After 2 weeks, the caps were loosened to promote bioﬁlm formation. M. tuberculosis was also
cultured in Sauton’s medium without Tween 80 in 6-well or 24-well plates, where the dishes were kept
in a sealed Tupperware container for 3 weeks before the lid was opened and the bacterium was cultured
further.
Lipid isolation and analysis. To harvest total lipids, cultures were harvested by centrifugation and
resuspended in chloroform-methanol (2:1, vol/vol). Surface lipids were extracted from M. tuberculosis
bioﬁlms as described previously (12). Brieﬂy, bioﬁlms were harvested and were resuspended in 5 ml of
hexanes; then they were agitated with glass beads for 3 min. After centrifugation at 3,000 ⫻ g for 5 min,
the hexane-extracted lipids were removed and an equal volume of chloroform-methanol (2:1, vol/vol)
added before removal from the biosafety level 3 (BSL3) laboratory. Following extraction, surface and total
lipids were dried under N2 gas. Total and surface lipids were resuspended in chloroform-methanol (2:1,
vol/vol), and equivalent amounts were spotted onto thin-layer chromatography (TLC) plates. TMM, TDM,
and free mycolic acids were resolved by TLC in the chloroform-methanol-dH2O (90:10:1, vol/vol/vol)
solvent system. Triacylglycerol (TAG) was resolved by TLC in the toluene-acetone (99:1, vol/vol) solvent
system. The TLC plates were visualized by spraying with 5% molybdophosphoric acid (MPA) in ethanol
and were charred. Lipids were puriﬁed from silica plates (Analtech) using standard preparative TLC
procedures.
MS. Structural analysis of lipids was conducted on a Thermo Scientiﬁc (San Jose, CA) TSQ Vantage
EMR mass spectrometer with an Xcalibur operating system. Fractionated lipids from preparative TLC
were loop injected, subjected to electrospray ionization (ESI), and analyzed as described previously
(10, 55).
Microscopy. For analysis of bacterial cell length, M. tuberculosis bacteria were ﬁxed overnight at 4°C
in 10% buffered formalin. Bacteria were washed with PBS and were heat-ﬁxed to 1.5-mm glass coverslips.
After rinsing with deionized (DI) water, coverslips were mounted to slides using Fluoromount-G (Southern Biotech). Slides were visualized at the OHSU Advanced Light Microscopy Core using ⫻60 magniﬁcation on a Deltavision CoreDV Wideﬁeld deconvolution system. Cell length was measured using Fiji
software (56), and subsequent statistical analysis was performed using GraphPad Prism.
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For ultrastructural analysis of M. tuberculosis, bacteria were ﬁxed overnight in 4% formaldehyde–1%
glutaraldehyde in 0.1 M cacodylate buffer (pH 7.2). Fixed samples were embedded in Spurr’s epoxy resin.
Transmission electron microscopy was performed at the Multiscale Microscopy Core (MMC) on an FEI
Tecnai Spirit TEM system with technical support from the OHSU-FEI Living Lab and the OHSU Center for
Spatial Systems Biomedicine (OCSSB). Images were acquired as 2,048-by-2,048-pixel, 16-bit grayscale ﬁles
using the FEI’s TEM Imaging & Analysis (TIA) interface on an Eagle 2K charge-coupled device (CCD)
multiscan camera.
For the imaging of in vitro granuloma structures, cells on glass coverslips were ﬁrst ﬁxed with 4%
paraformaldehyde (PFA) for 20 min and then washed twice with PBS. For CD68, CD163, and CD206
staining, cells were treated with ice-cold methanol for 5 min, washed three times with PBS, and
incubated in blocking buffer (5% BSA–10% goat serum–PBS) for 1 h at room temperature (RT). Cells were
then incubated with primary antibodies against CD3 (UCHT1; Biolegend), CD68 (PG-M1; Dako), CD163
(GH1/61; Thermo Scientiﬁc), or CD206 (19.2; BD Biosciences) for 1 h in blocking buffer, washed, and then
incubated with secondary antibodies in blocking buffer. After 1 h, cell were washed, stained with
4=,6-diamidino-2-phenylindole (DAPI), and mounted with ProLong Gold antifade reagent. In certain wells,
bacteria were stained with TB auramine-rhodamine stain (BD Biosciences), granuloma structures were
labeled with DAPI, and coverslips were mounted with ProLong Gold antifade reagent. Cells were imaged
with an Olympus FV1000 confocal microscope.
Intracellular survival and bacterial replication in differentiated THP-1 cells. THP-1 cells were
cultured in 90% RPMI 1640 medium (HyClone) with 10% heat-inactivated fetal bovine serum (FBS;
Sigma), supplemented with 2 mM L-glutamine (HyClone). THP-1 cells were seeded at a density of 1 ⫻
104/well in 96-well ﬂat-bottom plates in a medium containing 30 ng/ml phorbol-12-myristate-13-acetate
(PMA) for 48 h. Differentiated THP-1 cells were infected at a multiplicity of infection (MOI) of 1:1 for 1 h
and were then washed with medium to remove extracellular bacteria. At the time points indicated in Fig.
5A, THP-1 cells were lysed with 0.1% Tween 80, serially diluted, and plated on 7H11 agar plates to
determine the CFU of surviving M. tuberculosis.
In vitro granuloma model. Granulomas were generated as described elsewhere (30). Brieﬂy, blood
was collected from otherwise healthy individuals who had a positive result with the Mantoux tuberculin
skin test (TST) and/or IFN-␥ release assay (IGRA) within the previous 12 months following an Ohio State
University-approved IRB protocol. PBMCs were isolated on a Ficoll-Paque cushion according to standard
protocols (57), and 2 ⫻ 106 PBMCs/ml were immediately infected with M. tuberculosis at an MOI of
1:1 in 10% autologous serum–RPMI, in triplicate. Serum was replenished after 4 days, and cells were
incubated for a total of 7 days at 37°C under 5% CO2. With this method, the granulomas are stable for
up to 12 days. Cells were lysed as described previously (58), diluted, and plated on Middlebrook 7H11
agar plates, in triplicate, for CFU enumeration. The stage of granuloma formation was determined
semiquantitatively for each experimental group. Each sample (well) was assessed by light microscopy
under a 40⫻ lens (Olympus IX71 DP71 microscope digital camera), and images were taken to establish
a scoring index, as described previously (30). Brieﬂy, this index ranks the granuloma structure on a scale
of 1 to 5, based on progressive increases in the size and speciﬁc cell distribution of granulomas, such that
1 indicates no cell aggregation and 5 indicates large granuloma-like structures with macrophages
surrounded by lymphocytes.
IFN-␥ ELISPOT assays. Monocyte-derived dendritic cells (DCs) were isolated as described previously
(59) and were infected with wild-type M. tuberculosis or the mmpL11 mutant (MOI, 5) for 18 h. Some
infected DCs were lysed to determine bacterial CFU counts. The remaining cells were used as antigenpresenting cells in an IFN-␥ enzyme-linked immunosorbent spot (ELISPOT) assay. A total of 10,000
infected DCs were plated in each well, and the IFN-␥ response of 20,000 CD8⫹ T cell clones was
measured. The clones used were restricted by HLA-B0801 (D454 B10), HLA-B1501 (D454 H1-2), HLAB0801 (D480 F6), or HLA-B5701 (D504 F9). D454 B10 recognizes M. tuberculosis peptide EsxG53– 61. D454
H1-2 recognizes M. tuberculosis peptide Mtb8.433– 43. D480 F6 recognizes M. tuberculosis peptide
CFP103–11 (60). D504 F9 recognizes M. tuberculosis peptide EsxJ24 –34 (61). The response of the T cell clones
to DCs infected with the mmpL11 mutant strain is shown in Fig. S4A as a percentage of the response to
DCs infected with wild-type M. tuberculosis.
Ethidium bromide uptake assays. To assess membrane permeability, an ethidium bromide uptake
assay on intact mycobacteria was performed essentially as described previously (62). Brieﬂy, logarithmicphase M. tuberculosis strains grown in 7H9 ADS Tween medium (OD600, 0.5 to 1.0) were centrifuged,
normalized to an OD600 of 0.5 in uptake buffer (50 mM KH2PO4 [pH 7.0], 5 mM MgSO4), and preenergized
with 25 mM glucose for 5 min. One hundred microliters of cells was added per well of black, clear-bottom
96-well microplates (Corning). Ethidium bromide was added to a ﬁnal concentration of 20 M. The
accumulation of ethidium bromide was followed over time by monitoring emission at 590 nm upon
excitation at 530 nm, and results were expressed as relative ﬂuorescence units.
Western blot analysis. Logarithmic-phase mycobacterial cultures grown in 7H9 medium (OD600, 0.5
to 1.0) were normalized to an OD600 of 1.0, washed once in PBS, and resuspended in Sauton’s medium
without Tween 80. Standing cultures were maintained at 37°C for 5 days, the bacteria were pelleted
by centrifugation, and the supernatant was precipitated by the addition of trichloroacetic acid (TCA) to
a ﬁnal concentration of 10% (vol/vol). Following centrifugation, the pellet containing culture ﬁltrate
proteins (CFP) was washed with acetone and was resuspended in 1⫻ SDS-PAGE loading buffer. Total
lysates were obtained by bead-beating cell pellets. Proteins were resolved by SDS–15% PAGE, transferred
to nitrocellulose membranes, and probed with antibodies against secreted proteins Antigen 85
(NR13800; BEI Resources) and ESAT-6 (NR13803; BEI Resources) and cytosolic protein KatG (NR13793; BEI
Resources).
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In vitro dormancy model for M. tuberculosis. We starved M. tuberculosis of nutrients by suspension
in PBS with modiﬁcations to a previously published protocol (63). We pelleted exponential-phase M.
tuberculosis to prepare cultures at a ﬁnal density of 1 ⫻ 108 cells ml⫺1. M. tuberculosis was washed twice
in PBS and was then resuspended in PBS. Dilutions of the ﬁnal bacterial suspension were plated for
enumeration of the starting inoculum. Cultures were incubated in closed tubes at 37°C for durations of
2 and 6 weeks and were then plated to determine the numbers of viable bacteria.
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